Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

Erstveröffentlichung
2021Authors
Müller, V
Banys-Paluchowski, M.
Friedl, T. W. P.
Fasching, P. A.
Schneeweiss, Andreas
Wissenschaftlicher Artikel
Published in
ESMO Open ; 6 (2021), 6. - Art.-Nr. 100299. - eISSN 2059-7029
Link to publication
https://dx.doi.org/10.1016/j.esmoop.2021.100299Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: breast cancer | circulating tumor cell | liquid biopsy | HER2 status | survival | EXPRESSION | RECEPTOR | AMPLIFICATION | MULTICENTER | ESTROGEN | THERAPY | DNA[DDC subject group]: DDC 610 / Medicine & health